nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—SHBG—obesity	0.329	0.769	CbGaD
Norethindrone—ALB—obesity	0.099	0.231	CbGaD
Norethindrone—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0493	0.153	CbGbCtD
Norethindrone—CYP3A7—Cimetidine—obesity	0.0493	0.153	CbGbCtD
Norethindrone—CYP3A5—Cimetidine—obesity	0.037	0.115	CbGbCtD
Norethindrone—CYP3A4—Sibutramine—obesity	0.0305	0.0947	CbGbCtD
Norethindrone—CYP2C19—Cimetidine—obesity	0.0298	0.0926	CbGbCtD
Norethindrone—ABCB1—Cimetidine—obesity	0.0241	0.0747	CbGbCtD
Norethindrone—CYP3A4—Benzphetamine—obesity	0.0231	0.0717	CbGbCtD
Norethindrone—CYP3A4—Bupropion—obesity	0.0196	0.061	CbGbCtD
Norethindrone—CYP2C19—Topiramate—obesity	0.0195	0.0606	CbGbCtD
Norethindrone—CYP3A4—Orlistat—obesity	0.016	0.0497	CbGbCtD
Norethindrone—CYP3A4—Cimetidine—obesity	0.0144	0.0448	CbGbCtD
Norethindrone—CYP3A4—Topiramate—obesity	0.00944	0.0293	CbGbCtD
Norethindrone—PGR—ovarian follicle—obesity	0.00772	0.245	CbGeAlD
Norethindrone—SHBG—hindbrain—obesity	0.00185	0.0588	CbGeAlD
Norethindrone—PGR—hindbrain—obesity	0.00167	0.053	CbGeAlD
Norethindrone—ALB—gall bladder—obesity	0.00151	0.0479	CbGeAlD
Norethindrone—Norelgestromin—STS—obesity	0.00127	0.175	CrCbGaD
Norethindrone—PGR—respiratory system—obesity	0.00102	0.0324	CbGeAlD
Norethindrone—CYP3A7—endocrine gland—obesity	0.000884	0.0281	CbGeAlD
Norethindrone—SHBG—cardiovascular system—obesity	0.000866	0.0275	CbGeAlD
Norethindrone—CYP3A7—liver—obesity	0.000797	0.0253	CbGeAlD
Norethindrone—PGR—cardiovascular system—obesity	0.00078	0.0248	CbGeAlD
Norethindrone—SHBG—pituitary gland—obesity	0.000767	0.0244	CbGeAlD
Norethindrone—SHBG—adipose tissue—obesity	0.000764	0.0243	CbGeAlD
Norethindrone—Insomnia—Methamphetamine—obesity	0.000719	0.00539	CcSEcCtD
Norethindrone—Tension—Phenylpropanolamine—obesity	0.000718	0.00538	CcSEcCtD
Norethindrone—Nervousness—Phenylpropanolamine—obesity	0.00071	0.00532	CcSEcCtD
Norethindrone—Amenorrhoea—Bupropion—obesity	0.000703	0.00526	CcSEcCtD
Norethindrone—Dyspepsia—Methamphetamine—obesity	0.0007	0.00524	CcSEcCtD
Norethindrone—Insomnia—Benzphetamine—obesity	0.000694	0.0052	CcSEcCtD
Norethindrone—PGR—pituitary gland—obesity	0.000691	0.0219	CbGeAlD
Norethindrone—PGR—adipose tissue—obesity	0.000688	0.0219	CbGeAlD
Norethindrone—Tension—Phentermine—obesity	0.000687	0.00515	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Methamphetamine—obesity	0.000687	0.00514	CcSEcCtD
Norethindrone—SHBG—adrenal gland—obesity	0.000685	0.0218	CbGeAlD
Norethindrone—Nervousness—Phentermine—obesity	0.00068	0.00509	CcSEcCtD
Norethindrone—CYP3A7-CYP3A51P—liver—obesity	0.000678	0.0215	CbGeAlD
Norethindrone—Dyspepsia—Benzphetamine—obesity	0.000675	0.00506	CcSEcCtD
Norethindrone—Hepatitis—Cimetidine—obesity	0.000666	0.00499	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Benzphetamine—obesity	0.000662	0.00496	CcSEcCtD
Norethindrone—Deep vein thrombosis—Topiramate—obesity	0.000647	0.00484	CcSEcCtD
Norethindrone—Insomnia—Phendimetrazine—obesity	0.000632	0.00474	CcSEcCtD
Norethindrone—Urticaria—Methamphetamine—obesity	0.000632	0.00473	CcSEcCtD
Norethindrone—Erythema multiforme—Cimetidine—obesity	0.000629	0.00471	CcSEcCtD
Norethindrone—CYP3A5—islet of Langerhans—obesity	0.000627	0.0199	CbGeAlD
Norethindrone—Alopecia—Diethylpropion—obesity	0.000618	0.00463	CcSEcCtD
Norethindrone—Pulmonary embolism—Bupropion—obesity	0.000617	0.00463	CcSEcCtD
Norethindrone—PGR—adrenal gland—obesity	0.000617	0.0196	CbGeAlD
Norethindrone—Embolism—Topiramate—obesity	0.000613	0.00459	CcSEcCtD
Norethindrone—Urticaria—Benzphetamine—obesity	0.000609	0.00456	CcSEcCtD
Norethindrone—Tension—Diethylpropion—obesity	0.000598	0.00448	CcSEcCtD
Norethindrone—SHBG—endocrine gland—obesity	0.000594	0.0189	CbGeAlD
Norethindrone—CYP3A5—respiratory system—obesity	0.000593	0.0188	CbGeAlD
Norethindrone—Nervousness—Diethylpropion—obesity	0.000591	0.00443	CcSEcCtD
Norethindrone—Alopecia—Cimetidine—obesity	0.000588	0.00441	CcSEcCtD
Norethindrone—Hypersensitivity—Methamphetamine—obesity	0.000586	0.00439	CcSEcCtD
Norethindrone—Photosensitivity—Sibutramine—obesity	0.000585	0.00439	CcSEcCtD
Norethindrone—Oedema—Phentermine—obesity	0.000571	0.00428	CcSEcCtD
Norethindrone—Flatulence—Cimetidine—obesity	0.000571	0.00428	CcSEcCtD
Norethindrone—ALB—adrenal gland—obesity	0.000566	0.018	CbGeAlD
Norethindrone—Hypersensitivity—Benzphetamine—obesity	0.000565	0.00423	CcSEcCtD
Norethindrone—Abdominal pain—Phendimetrazine—obesity	0.000553	0.00414	CcSEcCtD
Norethindrone—Metrorrhagia—Topiramate—obesity	0.000551	0.00413	CcSEcCtD
Norethindrone—Renal impairment—Sibutramine—obesity	0.00054	0.00405	CcSEcCtD
Norethindrone—Insomnia—Phenylpropanolamine—obesity	0.00054	0.00405	CcSEcCtD
Norethindrone—SHBG—liver—obesity	0.000536	0.017	CbGeAlD
Norethindrone—PGR—endocrine gland—obesity	0.000535	0.017	CbGeAlD
Norethindrone—Purpura—Sibutramine—obesity	0.000533	0.004	CcSEcCtD
Norethindrone—Dermatitis atopic—Topiramate—obesity	0.000531	0.00398	CcSEcCtD
Norethindrone—Vaginal haemorrhage—Topiramate—obesity	0.000531	0.00398	CcSEcCtD
Norethindrone—Menorrhagia—Topiramate—obesity	0.000531	0.00398	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Sibutramine—obesity	0.000531	0.00398	CcSEcCtD
Norethindrone—Somnolence—Phenylpropanolamine—obesity	0.000531	0.00398	CcSEcCtD
Norethindrone—Convulsion—Diethylpropion—obesity	0.000528	0.00395	CcSEcCtD
Norethindrone—Dizziness—Methamphetamine—obesity	0.000526	0.00394	CcSEcCtD
Norethindrone—Insomnia—Phentermine—obesity	0.000517	0.00387	CcSEcCtD
Norethindrone—Pain in extremity—Sibutramine—obesity	0.000514	0.00385	CcSEcCtD
Norethindrone—Photosensitivity—Bupropion—obesity	0.00051	0.00382	CcSEcCtD
Norethindrone—Dizziness—Benzphetamine—obesity	0.000507	0.0038	CcSEcCtD
Norethindrone—Migraine—Sibutramine—obesity	0.000506	0.00379	CcSEcCtD
Norethindrone—Affect lability—Sibutramine—obesity	0.000506	0.00379	CcSEcCtD
Norethindrone—Dyspepsia—Phentermine—obesity	0.000503	0.00377	CcSEcCtD
Norethindrone—Headache—Methamphetamine—obesity	0.000498	0.00373	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Phentermine—obesity	0.000493	0.00369	CcSEcCtD
Norethindrone—Fatigue—Phentermine—obesity	0.000493	0.00369	CcSEcCtD
Norethindrone—Mood swings—Sibutramine—obesity	0.000487	0.00365	CcSEcCtD
Norethindrone—Headache—Benzphetamine—obesity	0.00048	0.0036	CcSEcCtD
Norethindrone—Breast disorder—Orlistat—obesity	0.00048	0.0036	CcSEcCtD
Norethindrone—CYP2C19—digestive system—obesity	0.000478	0.0152	CbGeAlD
Norethindrone—Anaphylactic shock—Cimetidine—obesity	0.000473	0.00354	CcSEcCtD
Norethindrone—Acne—Topiramate—obesity	0.000467	0.0035	CcSEcCtD
Norethindrone—Abdominal distension—Orlistat—obesity	0.000462	0.00346	CcSEcCtD
Norethindrone—Dizziness—Phendimetrazine—obesity	0.000462	0.00346	CcSEcCtD
Norethindrone—Nausea—Benzphetamine—obesity	0.000455	0.00341	CcSEcCtD
Norethindrone—Urticaria—Phentermine—obesity	0.000454	0.0034	CcSEcCtD
Norethindrone—Abdominal pain—Phentermine—obesity	0.000452	0.00338	CcSEcCtD
Norethindrone—Breast pain—Topiramate—obesity	0.000451	0.00338	CcSEcCtD
Norethindrone—Insomnia—Diethylpropion—obesity	0.00045	0.00337	CcSEcCtD
Norethindrone—Pain in extremity—Bupropion—obesity	0.000448	0.00336	CcSEcCtD
Norethindrone—Amenorrhoea—Topiramate—obesity	0.000448	0.00335	CcSEcCtD
Norethindrone—Abdominal distension—Sibutramine—obesity	0.000447	0.00335	CcSEcCtD
Norethindrone—ALB—liver—obesity	0.000442	0.0141	CbGeAlD
Norethindrone—Somnolence—Diethylpropion—obesity	0.000442	0.00331	CcSEcCtD
Norethindrone—Affect lability—Bupropion—obesity	0.000441	0.0033	CcSEcCtD
Norethindrone—Migraine—Bupropion—obesity	0.000441	0.0033	CcSEcCtD
Norethindrone—Hypersensitivity—Phenylpropanolamine—obesity	0.00044	0.0033	CcSEcCtD
Norethindrone—Headache—Phendimetrazine—obesity	0.000438	0.00328	CcSEcCtD
Norethindrone—Dyspepsia—Diethylpropion—obesity	0.000438	0.00328	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Diethylpropion—obesity	0.000429	0.00321	CcSEcCtD
Norethindrone—Mood swings—Bupropion—obesity	0.000425	0.00318	CcSEcCtD
Norethindrone—Somnolence—Cimetidine—obesity	0.00042	0.00315	CcSEcCtD
Norethindrone—Nausea—Phendimetrazine—obesity	0.000415	0.00311	CcSEcCtD
Norethindrone—Asthenia—Phentermine—obesity	0.00041	0.00307	CcSEcCtD
Norethindrone—Depression—Orlistat—obesity	0.000408	0.00306	CcSEcCtD
Norethindrone—Fatigue—Cimetidine—obesity	0.000408	0.00305	CcSEcCtD
Norethindrone—Photosensitivity reaction—Sibutramine—obesity	0.000406	0.00304	CcSEcCtD
Norethindrone—Breast disorder—Bupropion—obesity	0.000405	0.00303	CcSEcCtD
Norethindrone—Weight increased—Sibutramine—obesity	0.000404	0.00303	CcSEcCtD
Norethindrone—Renal failure—Orlistat—obesity	0.000402	0.00301	CcSEcCtD
Norethindrone—CYP3A5—adipose tissue—obesity	0.0004	0.0127	CbGeAlD
Norethindrone—CYP2C19—endocrine gland—obesity	0.000395	0.0125	CbGeAlD
Norethindrone—Depression—Sibutramine—obesity	0.000395	0.00296	CcSEcCtD
Norethindrone—Urticaria—Diethylpropion—obesity	0.000395	0.00296	CcSEcCtD
Norethindrone—Dizziness—Phenylpropanolamine—obesity	0.000395	0.00296	CcSEcCtD
Norethindrone—Pulmonary embolism—Topiramate—obesity	0.000393	0.00295	CcSEcCtD
Norethindrone—Acute coronary syndrome—Sibutramine—obesity	0.000391	0.00293	CcSEcCtD
Norethindrone—Abdominal distension—Bupropion—obesity	0.00039	0.00292	CcSEcCtD
Norethindrone—Renal failure—Sibutramine—obesity	0.000389	0.00292	CcSEcCtD
Norethindrone—Myocardial infarction—Sibutramine—obesity	0.000388	0.00291	CcSEcCtD
Norethindrone—Hepatobiliary disease—Orlistat—obesity	0.000387	0.0029	CcSEcCtD
Norethindrone—Vomiting—Phenylpropanolamine—obesity	0.00038	0.00284	CcSEcCtD
Norethindrone—Dizziness—Phentermine—obesity	0.000378	0.00283	CcSEcCtD
Norethindrone—CYP3A5—digestive system—obesity	0.000377	0.012	CbGeAlD
Norethindrone—Rash—Phenylpropanolamine—obesity	0.000376	0.00282	CcSEcCtD
Norethindrone—Dermatitis—Phenylpropanolamine—obesity	0.000376	0.00282	CcSEcCtD
Norethindrone—Haemoglobin—Orlistat—obesity	0.000369	0.00277	CcSEcCtD
Norethindrone—Hepatitis—Orlistat—obesity	0.000367	0.00275	CcSEcCtD
Norethindrone—Haemorrhage—Orlistat—obesity	0.000367	0.00275	CcSEcCtD
Norethindrone—Vomiting—Phentermine—obesity	0.000363	0.00272	CcSEcCtD
Norethindrone—Rash—Phentermine—obesity	0.00036	0.0027	CcSEcCtD
Norethindrone—Dermatitis—Phentermine—obesity	0.00036	0.0027	CcSEcCtD
Norethindrone—Headache—Phentermine—obesity	0.000358	0.00268	CcSEcCtD
Norethindrone—Haemoglobin—Sibutramine—obesity	0.000357	0.00268	CcSEcCtD
Norethindrone—CYP2C19—liver—obesity	0.000356	0.0113	CbGeAlD
Norethindrone—Haemorrhage—Sibutramine—obesity	0.000356	0.00266	CcSEcCtD
Norethindrone—Nausea—Phenylpropanolamine—obesity	0.000355	0.00266	CcSEcCtD
Norethindrone—Photosensitivity reaction—Bupropion—obesity	0.000354	0.00265	CcSEcCtD
Norethindrone—Weight increased—Bupropion—obesity	0.000353	0.00264	CcSEcCtD
Norethindrone—Hypersensitivity—Cimetidine—obesity	0.000348	0.00261	CcSEcCtD
Norethindrone—Levonorgestrel—SRD5A1—obesity	0.000341	0.047	CrCbGaD
Norethindrone—Acute coronary syndrome—Bupropion—obesity	0.00034	0.00255	CcSEcCtD
Norethindrone—Nausea—Phentermine—obesity	0.000339	0.00254	CcSEcCtD
Norethindrone—Asthenia—Cimetidine—obesity	0.000339	0.00254	CcSEcCtD
Norethindrone—Myocardial infarction—Bupropion—obesity	0.000339	0.00254	CcSEcCtD
Norethindrone—ABCB1—islet of Langerhans—obesity	0.000333	0.0106	CbGeAlD
Norethindrone—Immune system disorder—Orlistat—obesity	0.000332	0.00249	CcSEcCtD
Norethindrone—Dizziness—Diethylpropion—obesity	0.000329	0.00246	CcSEcCtD
Norethindrone—Alopecia—Orlistat—obesity	0.000325	0.00243	CcSEcCtD
Norethindrone—Mental disorder—Orlistat—obesity	0.000322	0.00241	CcSEcCtD
Norethindrone—Immune system disorder—Sibutramine—obesity	0.000321	0.00241	CcSEcCtD
Norethindrone—Vomiting—Diethylpropion—obesity	0.000316	0.00237	CcSEcCtD
Norethindrone—Flatulence—Orlistat—obesity	0.000315	0.00236	CcSEcCtD
Norethindrone—ABCB1—respiratory system—obesity	0.000315	0.01	CbGeAlD
Norethindrone—Alopecia—Sibutramine—obesity	0.000314	0.00235	CcSEcCtD
Norethindrone—Rash—Diethylpropion—obesity	0.000313	0.00235	CcSEcCtD
Norethindrone—Dermatitis—Diethylpropion—obesity	0.000313	0.00235	CcSEcCtD
Norethindrone—Dizziness—Cimetidine—obesity	0.000313	0.00234	CcSEcCtD
Norethindrone—Haemoglobin—Bupropion—obesity	0.000312	0.00233	CcSEcCtD
Norethindrone—Headache—Diethylpropion—obesity	0.000311	0.00233	CcSEcCtD
Norethindrone—CYP3A5—endocrine gland—obesity	0.000311	0.00989	CbGeAlD
Norethindrone—Haemorrhage—Bupropion—obesity	0.00031	0.00232	CcSEcCtD
Norethindrone—Hepatitis—Bupropion—obesity	0.00031	0.00232	CcSEcCtD
Norethindrone—Flatulence—Sibutramine—obesity	0.000305	0.00229	CcSEcCtD
Norethindrone—Connective tissue disorder—Bupropion—obesity	0.000305	0.00228	CcSEcCtD
Norethindrone—Tension—Sibutramine—obesity	0.000304	0.00228	CcSEcCtD
Norethindrone—Nervousness—Sibutramine—obesity	0.000301	0.00225	CcSEcCtD
Norethindrone—Vomiting—Cimetidine—obesity	0.000301	0.00225	CcSEcCtD
Norethindrone—Rash—Cimetidine—obesity	0.000298	0.00223	CcSEcCtD
Norethindrone—Dermatitis—Cimetidine—obesity	0.000298	0.00223	CcSEcCtD
Norethindrone—Headache—Cimetidine—obesity	0.000296	0.00222	CcSEcCtD
Norethindrone—Purpura—Topiramate—obesity	0.000296	0.00222	CcSEcCtD
Norethindrone—Nausea—Diethylpropion—obesity	0.000295	0.00221	CcSEcCtD
Norethindrone—Erythema multiforme—Bupropion—obesity	0.000293	0.0022	CcSEcCtD
Norethindrone—Pain in extremity—Topiramate—obesity	0.000286	0.00214	CcSEcCtD
Norethindrone—Stanozolol—AR—obesity	0.000285	0.0393	CrCbGaD
Norethindrone—CYP3A4—digestive system—obesity	0.000283	0.00898	CbGeAlD
Norethindrone—Affect lability—Topiramate—obesity	0.000281	0.00211	CcSEcCtD
Norethindrone—Migraine—Topiramate—obesity	0.000281	0.00211	CcSEcCtD
Norethindrone—Nausea—Cimetidine—obesity	0.000281	0.0021	CcSEcCtD
Norethindrone—CYP3A5—liver—obesity	0.000281	0.00891	CbGeAlD
Norethindrone—Immune system disorder—Bupropion—obesity	0.00028	0.0021	CcSEcCtD
Norethindrone—Convulsion—Orlistat—obesity	0.000277	0.00208	CcSEcCtD
Norethindrone—Alopecia—Bupropion—obesity	0.000274	0.00205	CcSEcCtD
Norethindrone—Mental disorder—Bupropion—obesity	0.000272	0.00203	CcSEcCtD
Norethindrone—Mood swings—Topiramate—obesity	0.000271	0.00203	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00027	0.00203	CcSEcCtD
Norethindrone—Convulsion—Sibutramine—obesity	0.000268	0.00201	CcSEcCtD
Norethindrone—Flatulence—Bupropion—obesity	0.000266	0.00199	CcSEcCtD
Norethindrone—Tension—Bupropion—obesity	0.000265	0.00198	CcSEcCtD
Norethindrone—ABCB1—adrenal cortex—obesity	0.000264	0.00839	CbGeAlD
Norethindrone—Nervousness—Bupropion—obesity	0.000262	0.00196	CcSEcCtD
Norethindrone—Oedema—Orlistat—obesity	0.000261	0.00196	CcSEcCtD
Norethindrone—Anaphylactic shock—Orlistat—obesity	0.000261	0.00196	CcSEcCtD
Norethindrone—Breast disorder—Topiramate—obesity	0.000258	0.00193	CcSEcCtD
Norethindrone—Oxandrolone—AR—obesity	0.000256	0.0354	CrCbGaD
Norethindrone—Skin disorder—Orlistat—obesity	0.000254	0.0019	CcSEcCtD
Norethindrone—Oedema—Sibutramine—obesity	0.000253	0.00189	CcSEcCtD
Norethindrone—Anaphylactic shock—Sibutramine—obesity	0.000253	0.00189	CcSEcCtD
Norethindrone—Abdominal distension—Topiramate—obesity	0.000248	0.00186	CcSEcCtD
Norethindrone—Skin disorder—Sibutramine—obesity	0.000245	0.00184	CcSEcCtD
Norethindrone—ABCB1—cardiovascular system—obesity	0.000241	0.00766	CbGeAlD
Norethindrone—Insomnia—Orlistat—obesity	0.000236	0.00177	CcSEcCtD
Norethindrone—Convulsion—Bupropion—obesity	0.000234	0.00175	CcSEcCtD
Norethindrone—CYP3A4—endocrine gland—obesity	0.000234	0.00742	CbGeAlD
Norethindrone—Dyspepsia—Orlistat—obesity	0.00023	0.00172	CcSEcCtD
Norethindrone—Insomnia—Sibutramine—obesity	0.000229	0.00171	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000228	0.00171	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Orlistat—obesity	0.000225	0.00169	CcSEcCtD
Norethindrone—Photosensitivity reaction—Topiramate—obesity	0.000225	0.00169	CcSEcCtD
Norethindrone—Fatigue—Orlistat—obesity	0.000225	0.00169	CcSEcCtD
Norethindrone—Somnolence—Sibutramine—obesity	0.000225	0.00168	CcSEcCtD
Norethindrone—Weight increased—Topiramate—obesity	0.000225	0.00168	CcSEcCtD
Norethindrone—Dyspepsia—Sibutramine—obesity	0.000222	0.00167	CcSEcCtD
Norethindrone—Anaphylactic shock—Bupropion—obesity	0.00022	0.00165	CcSEcCtD
Norethindrone—Oedema—Bupropion—obesity	0.00022	0.00165	CcSEcCtD
Norethindrone—Depression—Topiramate—obesity	0.000219	0.00164	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Sibutramine—obesity	0.000218	0.00163	CcSEcCtD
Norethindrone—Renal failure—Topiramate—obesity	0.000216	0.00162	CcSEcCtD
Norethindrone—Skin disorder—Bupropion—obesity	0.000214	0.0016	CcSEcCtD
Norethindrone—Gastrointestinal pain—Orlistat—obesity	0.000213	0.0016	CcSEcCtD
Norethindrone—ABCB1—pituitary gland—obesity	0.000213	0.00678	CbGeAlD
Norethindrone—ABCB1—adipose tissue—obesity	0.000213	0.00675	CbGeAlD
Norethindrone—CYP3A4—liver—obesity	0.000211	0.00669	CbGeAlD
Norethindrone—Urticaria—Orlistat—obesity	0.000207	0.00155	CcSEcCtD
Norethindrone—Gastrointestinal pain—Sibutramine—obesity	0.000207	0.00155	CcSEcCtD
Norethindrone—Abdominal pain—Orlistat—obesity	0.000206	0.00155	CcSEcCtD
Norethindrone—Desogestrel—SHBG—obesity	0.000201	0.0278	CrCbGaD
Norethindrone—Urticaria—Sibutramine—obesity	0.000201	0.0015	CcSEcCtD
Norethindrone—Nandrolone phenpropionate—AR—obesity	0.000201	0.0277	CrCbGaD
Norethindrone—ABCB1—digestive system—obesity	0.0002	0.00636	CbGeAlD
Norethindrone—Abdominal pain—Sibutramine—obesity	0.0002	0.0015	CcSEcCtD
Norethindrone—Insomnia—Bupropion—obesity	0.000199	0.00149	CcSEcCtD
Norethindrone—Haemoglobin—Topiramate—obesity	0.000199	0.00149	CcSEcCtD
Norethindrone—Haemorrhage—Topiramate—obesity	0.000198	0.00148	CcSEcCtD
Norethindrone—Hepatitis—Topiramate—obesity	0.000198	0.00148	CcSEcCtD
Norethindrone—Somnolence—Bupropion—obesity	0.000196	0.00147	CcSEcCtD
Norethindrone—Connective tissue disorder—Topiramate—obesity	0.000194	0.00145	CcSEcCtD
Norethindrone—Dyspepsia—Bupropion—obesity	0.000194	0.00145	CcSEcCtD
Norethindrone—Hypersensitivity—Orlistat—obesity	0.000192	0.00144	CcSEcCtD
Norethindrone—ABCB1—adrenal gland—obesity	0.000191	0.00606	CbGeAlD
Norethindrone—Gastrointestinal disorder—Bupropion—obesity	0.00019	0.00142	CcSEcCtD
Norethindrone—Fatigue—Bupropion—obesity	0.00019	0.00142	CcSEcCtD
Norethindrone—Asthenia—Orlistat—obesity	0.000187	0.0014	CcSEcCtD
Norethindrone—Erythema multiforme—Topiramate—obesity	0.000187	0.0014	CcSEcCtD
Norethindrone—Hypersensitivity—Sibutramine—obesity	0.000186	0.00139	CcSEcCtD
Norethindrone—Pruritus—Orlistat—obesity	0.000185	0.00138	CcSEcCtD
Norethindrone—Danazol—CCL2—obesity	0.000184	0.0255	CrCbGaD
Norethindrone—Quinestrol—ESR1—obesity	0.000182	0.0251	CrCbGaD
Norethindrone—Asthenia—Sibutramine—obesity	0.000181	0.00136	CcSEcCtD
Norethindrone—Gastrointestinal pain—Bupropion—obesity	0.00018	0.00135	CcSEcCtD
Norethindrone—Pruritus—Sibutramine—obesity	0.000179	0.00134	CcSEcCtD
Norethindrone—Immune system disorder—Topiramate—obesity	0.000178	0.00134	CcSEcCtD
Norethindrone—Urticaria—Bupropion—obesity	0.000175	0.00131	CcSEcCtD
Norethindrone—Alopecia—Topiramate—obesity	0.000175	0.00131	CcSEcCtD
Norethindrone—Abdominal pain—Bupropion—obesity	0.000174	0.0013	CcSEcCtD
Norethindrone—Mental disorder—Topiramate—obesity	0.000173	0.0013	CcSEcCtD
Norethindrone—Dizziness—Orlistat—obesity	0.000173	0.00129	CcSEcCtD
Norethindrone—Flatulence—Topiramate—obesity	0.000169	0.00127	CcSEcCtD
Norethindrone—Ethinyl Estradiol—NR1I2—obesity	0.000169	0.0234	CrCbGaD
Norethindrone—Tension—Topiramate—obesity	0.000169	0.00126	CcSEcCtD
Norethindrone—Nandrolone phenpropionate—CYP19A1—obesity	0.000168	0.0232	CrCbGaD
Norethindrone—Dizziness—Sibutramine—obesity	0.000167	0.00125	CcSEcCtD
Norethindrone—Nervousness—Topiramate—obesity	0.000167	0.00125	CcSEcCtD
Norethindrone—Vomiting—Orlistat—obesity	0.000166	0.00124	CcSEcCtD
Norethindrone—ABCB1—endocrine gland—obesity	0.000165	0.00525	CbGeAlD
Norethindrone—Rash—Orlistat—obesity	0.000165	0.00123	CcSEcCtD
Norethindrone—Dermatitis—Orlistat—obesity	0.000164	0.00123	CcSEcCtD
Norethindrone—Headache—Orlistat—obesity	0.000164	0.00123	CcSEcCtD
Norethindrone—Etonogestrel—SHBG—obesity	0.000163	0.0225	CrCbGaD
Norethindrone—Hypersensitivity—Bupropion—obesity	0.000162	0.00122	CcSEcCtD
Norethindrone—Vomiting—Sibutramine—obesity	0.000161	0.0012	CcSEcCtD
Norethindrone—Rash—Sibutramine—obesity	0.000159	0.00119	CcSEcCtD
Norethindrone—Dermatitis—Sibutramine—obesity	0.000159	0.00119	CcSEcCtD
Norethindrone—Headache—Sibutramine—obesity	0.000158	0.00119	CcSEcCtD
Norethindrone—Asthenia—Bupropion—obesity	0.000158	0.00118	CcSEcCtD
Norethindrone—Pruritus—Bupropion—obesity	0.000156	0.00117	CcSEcCtD
Norethindrone—Nausea—Orlistat—obesity	0.000155	0.00116	CcSEcCtD
Norethindrone—Nandrolone decanoate—AR—obesity	0.000152	0.021	CrCbGaD
Norethindrone—Nausea—Sibutramine—obesity	0.00015	0.00112	CcSEcCtD
Norethindrone—Ethynodiol—ESR1—obesity	0.00015	0.0207	CrCbGaD
Norethindrone—ABCB1—liver—obesity	0.000149	0.00473	CbGeAlD
Norethindrone—Convulsion—Topiramate—obesity	0.000149	0.00112	CcSEcCtD
Norethindrone—Dizziness—Bupropion—obesity	0.000146	0.00109	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000145	0.00109	CcSEcCtD
Norethindrone—Allylestrenol—ESR1—obesity	0.000141	0.0195	CrCbGaD
Norethindrone—Oedema—Topiramate—obesity	0.00014	0.00105	CcSEcCtD
Norethindrone—Vomiting—Bupropion—obesity	0.00014	0.00105	CcSEcCtD
Norethindrone—Testosterone Propionate—COMT—obesity	0.000139	0.0193	CrCbGaD
Norethindrone—Rash—Bupropion—obesity	0.000139	0.00104	CcSEcCtD
Norethindrone—Dermatitis—Bupropion—obesity	0.000139	0.00104	CcSEcCtD
Norethindrone—Headache—Bupropion—obesity	0.000138	0.00103	CcSEcCtD
Norethindrone—Mestranol—ESR1—obesity	0.000138	0.019	CrCbGaD
Norethindrone—Skin disorder—Topiramate—obesity	0.000136	0.00102	CcSEcCtD
Norethindrone—Desogestrel—ESR1—obesity	0.000136	0.0188	CrCbGaD
Norethindrone—Nausea—Bupropion—obesity	0.000131	0.00098	CcSEcCtD
Norethindrone—Norgestimate—ESR1—obesity	0.000127	0.0176	CrCbGaD
Norethindrone—Nandrolone decanoate—CYP19A1—obesity	0.000127	0.0176	CrCbGaD
Norethindrone—Insomnia—Topiramate—obesity	0.000127	0.000951	CcSEcCtD
Norethindrone—Somnolence—Topiramate—obesity	0.000125	0.000935	CcSEcCtD
Norethindrone—Drospirenone—AR—obesity	0.000124	0.0171	CrCbGaD
Norethindrone—Dyspepsia—Topiramate—obesity	0.000124	0.000925	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Topiramate—obesity	0.000121	0.000908	CcSEcCtD
Norethindrone—Fatigue—Topiramate—obesity	0.000121	0.000906	CcSEcCtD
Norethindrone—Levonorgestrel—SHBG—obesity	0.000115	0.0159	CrCbGaD
Norethindrone—Gastrointestinal pain—Topiramate—obesity	0.000115	0.00086	CcSEcCtD
Norethindrone—Urticaria—Topiramate—obesity	0.000111	0.000835	CcSEcCtD
Norethindrone—Abdominal pain—Topiramate—obesity	0.000111	0.000831	CcSEcCtD
Norethindrone—Etonogestrel—ESR1—obesity	0.00011	0.0152	CrCbGaD
Norethindrone—Fluoxymesterone—SHBG—obesity	0.00011	0.0152	CrCbGaD
Norethindrone—Ethinyl Estradiol—ESR2—obesity	0.000107	0.0147	CrCbGaD
Norethindrone—Danazol—SHBG—obesity	0.000105	0.0145	CrCbGaD
Norethindrone—Testosterone Propionate—AR—obesity	0.000104	0.0144	CrCbGaD
Norethindrone—Drospirenone—BCHE—obesity	0.000103	0.0143	CrCbGaD
Norethindrone—Hypersensitivity—Topiramate—obesity	0.000103	0.000775	CcSEcCtD
Norethindrone—Levonorgestrel—AR—obesity	0.000101	0.014	CrCbGaD
Norethindrone—Asthenia—Topiramate—obesity	0.000101	0.000754	CcSEcCtD
Norethindrone—Cortisone acetate—NR3C1—obesity	9.98e-05	0.0138	CrCbGaD
Norethindrone—Pruritus—Topiramate—obesity	9.93e-05	0.000744	CcSEcCtD
Norethindrone—Ethinyl Estradiol—SHBG—obesity	9.72e-05	0.0134	CrCbGaD
Norethindrone—Fluoxymesterone—AR—obesity	9.63e-05	0.0133	CrCbGaD
Norethindrone—Dizziness—Topiramate—obesity	9.28e-05	0.000695	CcSEcCtD
Norethindrone—Danazol—AR—obesity	9.21e-05	0.0127	CrCbGaD
Norethindrone—Vomiting—Topiramate—obesity	8.92e-05	0.000668	CcSEcCtD
Norethindrone—Methyltestosterone—SHBG—obesity	8.87e-05	0.0122	CrCbGaD
Norethindrone—Rash—Topiramate—obesity	8.85e-05	0.000663	CcSEcCtD
Norethindrone—Dermatitis—Topiramate—obesity	8.84e-05	0.000662	CcSEcCtD
Norethindrone—Headache—Topiramate—obesity	8.79e-05	0.000659	CcSEcCtD
Norethindrone—Levonorgestrel—CYP19A1—obesity	8.46e-05	0.0117	CrCbGaD
Norethindrone—Nausea—Topiramate—obesity	8.34e-05	0.000624	CcSEcCtD
Norethindrone—Levonorgestrel—ESR1—obesity	7.79e-05	0.0108	CrCbGaD
Norethindrone—Methyltestosterone—AR—obesity	7.78e-05	0.0107	CrCbGaD
Norethindrone—Danazol—CYP19A1—obesity	7.71e-05	0.0106	CrCbGaD
Norethindrone—Fluoxymesterone—ESR1—obesity	7.42e-05	0.0102	CrCbGaD
Norethindrone—Danazol—ESR1—obesity	7.09e-05	0.00979	CrCbGaD
Norethindrone—Hydrocortisone—SHBG—obesity	6.68e-05	0.00923	CrCbGaD
Norethindrone—Ethinyl Estradiol—ESR1—obesity	6.56e-05	0.00906	CrCbGaD
Norethindrone—Fluoxymesterone—NR3C1—obesity	6.53e-05	0.00902	CrCbGaD
Norethindrone—Methyltestosterone—CYP19A1—obesity	6.51e-05	0.00899	CrCbGaD
Norethindrone—Progesterone—SHBG—obesity	5.44e-05	0.00752	CrCbGaD
Norethindrone—Progesterone—SLC22A1—obesity	5.37e-05	0.00742	CrCbGaD
Norethindrone—Testosterone—SHBG—obesity	5.15e-05	0.00711	CrCbGaD
Norethindrone—Testosterone—SLC22A1—obesity	5.08e-05	0.00701	CrCbGaD
Norethindrone—Progesterone—AR—obesity	4.77e-05	0.00659	CrCbGaD
Norethindrone—Drospirenone—PTGS2—obesity	4.77e-05	0.00658	CrCbGaD
Norethindrone—Testosterone—AR—obesity	4.51e-05	0.00623	CrCbGaD
Norethindrone—Hydrocortisone—NR3C1—obesity	3.97e-05	0.00549	CrCbGaD
Norethindrone—Testosterone—CYP19A1—obesity	3.78e-05	0.00521	CrCbGaD
Norethindrone—Progesterone—ESR1—obesity	3.68e-05	0.00508	CrCbGaD
Norethindrone—Progesterone—NR3C1—obesity	3.24e-05	0.00447	CrCbGaD
Norethindrone—Methyltestosterone—ALB—obesity	2.67e-05	0.00368	CrCbGaD
Norethindrone—Testosterone—ALB—obesity	1.55e-05	0.00214	CrCbGaD
Norethindrone—CYP2C19—Metabolism—SREBF1—obesity	6.28e-06	8.1e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ECHS1—obesity	6.23e-06	8.04e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UCP2—obesity	6.23e-06	8.04e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSD11B1—obesity	6.23e-06	8.04e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UCP3—obesity	6.23e-06	8.04e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	6.2e-06	7.99e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—COMT—obesity	6.16e-06	7.94e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	6.14e-06	7.92e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADH1B—obesity	6.13e-06	7.91e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SREBF1—obesity	6.13e-06	7.91e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT2—obesity	6.11e-06	7.88e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GNB3—obesity	6.07e-06	7.83e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARGC1A—obesity	6.07e-06	7.83e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC2A4—obesity	6.07e-06	7.82e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GCG—obesity	6.07e-06	7.82e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—obesity	6.04e-06	7.79e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARGC1B—obesity	6.04e-06	7.79e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPAM—obesity	6.04e-06	7.79e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACSL1—obesity	6.04e-06	7.79e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—obesity	6.03e-06	7.77e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYCS—obesity	5.99e-06	7.72e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FASN—obesity	5.98e-06	7.71e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT2—obesity	5.96e-06	7.69e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—BCHE—obesity	5.95e-06	7.68e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GNAS—obesity	5.91e-06	7.62e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GGT1—obesity	5.87e-06	7.58e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT1—obesity	5.87e-06	7.58e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FADS1—obesity	5.86e-06	7.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HADH—obesity	5.86e-06	7.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PCK1—obesity	5.86e-06	7.56e-05	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—obesity	5.85e-06	7.54e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FASN—obesity	5.84e-06	7.53e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—BCHE—obesity	5.81e-06	7.49e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOB—obesity	5.79e-06	7.46e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NCOA1—obesity	5.79e-06	7.46e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CG—obesity	5.78e-06	7.46e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2E1—obesity	5.74e-06	7.41e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—STK11—obesity	5.7e-06	7.36e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP19A1—obesity	5.7e-06	7.36e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACP5—obesity	5.7e-06	7.35e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NQO1—obesity	5.68e-06	7.32e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—obesity	5.66e-06	7.3e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2E1—obesity	5.61e-06	7.23e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—obesity	5.58e-06	7.2e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	5.56e-06	7.17e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—G6PD—obesity	5.56e-06	7.17e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NQO1—obesity	5.54e-06	7.15e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—LPL—obesity	5.53e-06	7.13e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	5.51e-06	7.11e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—POMC—obesity	5.51e-06	7.1e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK8—obesity	5.5e-06	7.1e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SREBF2—obesity	5.49e-06	7.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HK1—obesity	5.49e-06	7.08e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—INS—obesity	5.48e-06	7.06e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GCG—obesity	5.45e-06	7.02e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC2A4—obesity	5.45e-06	7.02e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPX1—obesity	5.39e-06	6.95e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYCS—obesity	5.37e-06	6.93e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GCG—obesity	5.32e-06	6.85e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC2A4—obesity	5.32e-06	6.85e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—COMT—obesity	5.3e-06	6.84e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPA—obesity	5.3e-06	6.84e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT1—obesity	5.27e-06	6.8e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GGT1—obesity	5.27e-06	6.8e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CD36—obesity	5.25e-06	6.77e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYCS—obesity	5.25e-06	6.77e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GNB3—obesity	5.23e-06	6.74e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARGC1A—obesity	5.23e-06	6.74e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—obesity	5.2e-06	6.71e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NCOA1—obesity	5.19e-06	6.7e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPIN1—obesity	5.19e-06	6.69e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GGT1—obesity	5.15e-06	6.64e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT1—obesity	5.15e-06	6.64e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP19A1—obesity	5.12e-06	6.6e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—STK11—obesity	5.12e-06	6.6e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GNAS—obesity	5.09e-06	6.56e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CD—obesity	5.08e-06	6.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA5—obesity	5.08e-06	6.55e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NCOA1—obesity	5.07e-06	6.54e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—STAT3—obesity	5.03e-06	6.49e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—obesity	5.02e-06	6.47e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP19A1—obesity	5e-06	6.44e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—STK11—obesity	5e-06	6.44e-05	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—obesity	4.99e-06	6.43e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOB—obesity	4.99e-06	6.43e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—obesity	4.98e-06	6.42e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARA—obesity	4.88e-06	6.3e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—obesity	4.88e-06	6.29e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CLOCK—obesity	4.85e-06	6.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC22A1—obesity	4.85e-06	6.25e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—obesity	4.8e-06	6.19e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3R1—obesity	4.8e-06	6.19e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LPL—obesity	4.76e-06	6.14e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—COMT—obesity	4.76e-06	6.14e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AGT—obesity	4.73e-06	6.1e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GLP1R—obesity	4.72e-06	6.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SULT2A1—obesity	4.72e-06	6.09e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARGC1A—obesity	4.69e-06	6.05e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GNB3—obesity	4.69e-06	6.05e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—obesity	4.67e-06	6.03e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—obesity	4.67e-06	6.03e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—obesity	4.66e-06	6.01e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DPYD—obesity	4.65e-06	5.99e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—COMT—obesity	4.65e-06	5.99e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPX1—obesity	4.64e-06	5.99e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—obesity	4.63e-06	5.97e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAV1—obesity	4.59e-06	5.92e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARGC1A—obesity	4.58e-06	5.91e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GNB3—obesity	4.58e-06	5.91e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOA1—obesity	4.58e-06	5.91e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GNAS—obesity	4.57e-06	5.89e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—obesity	4.56e-06	5.88e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CD36—obesity	4.52e-06	5.83e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOB—obesity	4.48e-06	5.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PRKAR2B—obesity	4.47e-06	5.77e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GNAS—obesity	4.46e-06	5.75e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DCN—obesity	4.44e-06	5.73e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CB—obesity	4.43e-06	5.72e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—obesity	4.39e-06	5.66e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOB—obesity	4.37e-06	5.63e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CPT1A—obesity	4.32e-06	5.57e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—obesity	4.29e-06	5.53e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LPL—obesity	4.27e-06	5.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NAMPT—obesity	4.24e-06	5.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCK—obesity	4.21e-06	5.43e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LIPC—obesity	4.21e-06	5.43e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARA—obesity	4.2e-06	5.42e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOC3—obesity	4.18e-06	5.4e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CG—obesity	4.18e-06	5.39e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LPL—obesity	4.17e-06	5.38e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPX1—obesity	4.17e-06	5.38e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—obesity	4.15e-06	5.35e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AGT—obesity	4.07e-06	5.25e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPX1—obesity	4.07e-06	5.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CETP—obesity	4.06e-06	5.24e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CD36—obesity	4.06e-06	5.24e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—obesity	4.04e-06	5.2e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SDC1—obesity	4.02e-06	5.18e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—obesity	3.99e-06	5.15e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—POMC—obesity	3.98e-06	5.13e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—obesity	3.97e-06	5.12e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CD36—obesity	3.96e-06	5.11e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—INS—obesity	3.96e-06	5.1e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAV1—obesity	3.95e-06	5.1e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKR1C3—obesity	3.95e-06	5.1e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOA1—obesity	3.94e-06	5.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SCARB1—obesity	3.89e-06	5.02e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—obesity	3.85e-06	4.96e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.78e-06	4.87e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SREBF1—obesity	3.78e-06	4.87e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARA—obesity	3.77e-06	4.87e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—obesity	3.76e-06	4.84e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARA—obesity	3.68e-06	4.75e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CD—obesity	3.68e-06	4.74e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT2—obesity	3.67e-06	4.74e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AGT—obesity	3.66e-06	4.71e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—obesity	3.63e-06	4.68e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CG—obesity	3.6e-06	4.64e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FASN—obesity	3.6e-06	4.64e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—obesity	3.58e-06	4.62e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—BCHE—obesity	3.58e-06	4.62e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AGT—obesity	3.57e-06	4.6e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAV1—obesity	3.55e-06	4.58e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOA1—obesity	3.54e-06	4.57e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—obesity	3.51e-06	4.53e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—obesity	3.5e-06	4.51e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—obesity	3.48e-06	4.48e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—obesity	3.47e-06	4.48e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3R1—obesity	3.47e-06	4.48e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAV1—obesity	3.46e-06	4.47e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOA1—obesity	3.46e-06	4.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2E1—obesity	3.45e-06	4.45e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—POMC—obesity	3.43e-06	4.42e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NQO1—obesity	3.42e-06	4.4e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—INS—obesity	3.41e-06	4.4e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.39e-06	4.37e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—obesity	3.39e-06	4.37e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A4—obesity	3.27e-06	4.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCG—obesity	3.27e-06	4.22e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—obesity	3.24e-06	4.18e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CG—obesity	3.23e-06	4.17e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYCS—obesity	3.23e-06	4.17e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CB—obesity	3.2e-06	4.13e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—obesity	3.17e-06	4.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GGT1—obesity	3.17e-06	4.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT1—obesity	3.17e-06	4.09e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CD—obesity	3.17e-06	4.08e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CG—obesity	3.16e-06	4.07e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOA1—obesity	3.12e-06	4.03e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—obesity	3.12e-06	4.02e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP19A1—obesity	3.08e-06	3.97e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—STK11—obesity	3.08e-06	3.97e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—POMC—obesity	3.08e-06	3.97e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—INS—obesity	3.06e-06	3.95e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—obesity	3.05e-06	3.93e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—POMC—obesity	3e-06	3.87e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—obesity	2.99e-06	3.85e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3R1—obesity	2.99e-06	3.85e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—INS—obesity	2.99e-06	3.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—COMT—obesity	2.86e-06	3.69e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CD—obesity	2.84e-06	3.66e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GNB3—obesity	2.82e-06	3.64e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARGC1A—obesity	2.82e-06	3.64e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—obesity	2.81e-06	3.62e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—obesity	2.81e-06	3.62e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CD—obesity	2.77e-06	3.58e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CB—obesity	2.76e-06	3.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GNAS—obesity	2.75e-06	3.54e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—obesity	2.74e-06	3.53e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—obesity	2.73e-06	3.53e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—obesity	2.7e-06	3.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOB—obesity	2.69e-06	3.47e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—obesity	2.68e-06	3.46e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3R1—obesity	2.68e-06	3.46e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3R1—obesity	2.62e-06	3.38e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—obesity	2.62e-06	3.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPL—obesity	2.57e-06	3.31e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX1—obesity	2.51e-06	3.23e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CB—obesity	2.48e-06	3.19e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—obesity	2.45e-06	3.17e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CD36—obesity	2.44e-06	3.15e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CB—obesity	2.42e-06	3.12e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—obesity	2.4e-06	3.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—obesity	2.31e-06	2.98e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARA—obesity	2.27e-06	2.93e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—obesity	2.21e-06	2.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AGT—obesity	2.2e-06	2.83e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—obesity	2.15e-06	2.78e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAV1—obesity	2.13e-06	2.75e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA1—obesity	2.13e-06	2.75e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—obesity	1.95e-06	2.52e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CG—obesity	1.94e-06	2.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—obesity	1.88e-06	2.42e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—POMC—obesity	1.85e-06	2.39e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—INS—obesity	1.84e-06	2.37e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CD—obesity	1.71e-06	2.2e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—obesity	1.69e-06	2.18e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—obesity	1.68e-06	2.17e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3R1—obesity	1.61e-06	2.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—obesity	1.61e-06	2.08e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—obesity	1.6e-06	2.06e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—obesity	1.51e-06	1.95e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CB—obesity	1.49e-06	1.92e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—obesity	1.48e-06	1.9e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—obesity	1.47e-06	1.9e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—obesity	1.37e-06	1.77e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—obesity	1.23e-06	1.59e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—obesity	1.2e-06	1.55e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—obesity	9.08e-07	1.17e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—obesity	7.42e-07	9.57e-06	CbGpPWpGaD
